These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37828574)

  • 1. Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancer.
    He X; Peng Y; He G; Ye H; Liu L; Zhou Q; Shi J; Fu S; Wang J; Zhou Z; Li W
    J Transl Med; 2023 Oct; 21(1):717. PubMed ID: 37828574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Expression Level of PD1 by Tumor-Infiltrating CD8
    Kim HD; Song GW; Park S; Jung MK; Kim MH; Kang HJ; Yoo C; Yi K; Kim KH; Eo S; Moon DB; Hong SM; Ju YS; Shin EC; Hwang S; Park SH
    Gastroenterology; 2018 Dec; 155(6):1936-1950.e17. PubMed ID: 30145359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the immune checkpoint receptors PD-1, LAG3, and TIM3 in the immune context of stage II and III gastric cancer by using single and chromogenic multiplex immunohistochemistry.
    Park Y; Seo AN; Koh J; Nam SK; Kwak Y; Ahn SH; Park DJ; Kim HH; Lee HS
    Oncoimmunology; 2021; 10(1):1954761. PubMed ID: 34367732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD1/PDL1 expression is associated with increased TIM3 expression and tumor-infiltrating T lymphocytes in fibroblastic tumors.
    Chen H; Liu H; Ai J; Du X; Sun Y; Xiao S
    Clin Transl Oncol; 2022 Mar; 24(3):586-596. PubMed ID: 34741725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
    Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
    Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of PD1+TIM3+ tumor-infiltrating T cells in DLBCL and effects of PD1 or TIM3 blockade.
    Roussel M; Le KS; Granier C; Llamas Gutierrez F; Foucher E; Le Gallou S; Pangault C; Xerri L; Launay V; Lamy T; Tartour E; Olive D; Fest T
    Blood Adv; 2021 Apr; 5(7):1816-1829. PubMed ID: 33787861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD1
    Ma J; Zheng B; Goswami S; Meng L; Zhang D; Cao C; Li T; Zhu F; Ma L; Zhang Z; Zhang S; Duan M; Chen Q; Gao Q; Zhang X
    J Immunother Cancer; 2019 Nov; 7(1):331. PubMed ID: 31783783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8+CD103+PD1+TIM3+ T cells in glioblastoma microenvironment correlate with prognosis.
    Romagnoli G; D'Alessandris QG; Capone I; Tavilla A; Canini I; Lapenta C; Buccarelli M; Giordano M; Tirelli V; Sanchez M; Fragale A; Giannetti S; Di Bonaventura R; Lauretti L; Biffoni M; Ricci-Vitiani L; Pallini R; Gabriele L
    Immunology; 2024 Feb; 171(2):198-211. PubMed ID: 37884280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse large B-cell lymphoma: the significance of CD8
    Zhu Q; Yang Y; Chen K; Zhang Q; Huang Y; Jian S
    J Transl Med; 2024 Feb; 22(1):174. PubMed ID: 38369502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma.
    Guo XJ; Lu JC; Zeng HY; Zhou R; Sun QM; Yang GH; Pei YZ; Meng XL; Shen YH; Zhang PF; Cai JB; Huang PX; Ke AW; Shi YH; Zhou J; Fan J; Chen Y; Yang LX; Shi GM; Huang XY
    Front Immunol; 2021; 12():705378. PubMed ID: 34526987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of immunophenotypic characteristics, clinicopathological parameters and prognosis in gastric cancer microenvironment].
    Wu Y; Chen YQ; Shi TG; Tan NJ; Chen WC
    Zhonghua Yi Xue Za Zhi; 2023 Sep; 103(35):2786-2794. PubMed ID: 37723053
    [No Abstract]   [Full Text] [Related]  

  • 12. High CD8
    Fluxá P; Rojas-Sepúlveda D; Gleisner MA; Tittarelli A; Villegas P; Tapia L; Rivera MT; López MN; Catán F; Uribe M; Salazar-Onfray F
    BMC Cancer; 2018 Mar; 18(1):243. PubMed ID: 29499656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8
    Ge Z; Zhou G; Campos Carrascosa L; Gausvik E; Boor PPC; Noordam L; Doukas M; Polak WG; Terkivatan T; Pan Q; Takkenberg RB; Verheij J; Erdmann JI; IJzermans JNM; Peppelenbosch MP; Kraan J; Kwekkeboom J; Sprengers D
    Cell Mol Gastroenterol Hepatol; 2021; 12(2):443-464. PubMed ID: 33781741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative multiplex immunofluorescence analysis identifies infiltrating PD1
    Liang H; Li H; Xie Z; Jin T; Chen Y; Lv Z; Tan X; Li J; Han G; He W; Qiu N; Jiang M; Zhou J; Xia H; Zhan Y; Cui L; Guo W; Huang J; Zhang X; Wu YL
    Thorac Cancer; 2020 Oct; 11(10):2941-2954. PubMed ID: 32894006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of Breast Cancer and Insulin Resistance on PD1 and TIM3 Expression in Peripheral Blood CD8 T Cells.
    Martín-Manzo MV; Lara C; Vargas-de-Leon C; Carrero J; Queipo G; Fonseca-Sanchez M; Mejia-Dominguez NR; Kershenobich D; Mummidi S; Zentella-Dehesa A; Hernandez J
    Pathol Oncol Res; 2019 Jul; 25(3):1233-1243. PubMed ID: 30759303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of immune checkpoint blockade on antigen-specific CD8
    Ogando-Rivas E; Castillo P; Jones N; Trivedi V; Drake J; Dechkovskaia A; Candelario KM; Yang C; Mitchell DA
    Microbiol Immunol; 2022 May; 66(5):201-211. PubMed ID: 35150167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Microenvironment in Gallbladder Adenocarcinomas.
    Patil PA; Lombardo K; Cao W
    Appl Immunohistochem Mol Morphol; 2021 Sep; 29(8):557-563. PubMed ID: 33710123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune parameters associated with survival in metaplastic breast cancer.
    Chao X; Liu L; Sun P; Yang X; Li M; Luo R; Huang Y; He J; Yun J
    Breast Cancer Res; 2020 Aug; 22(1):92. PubMed ID: 32811533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune checkpoint proteins PD-1 and TIM-3 are both highly expressed in liver tissues and correlate with their gene polymorphisms in patients with HBV-related hepatocellular carcinoma.
    Li Z; Li N; Li F; Zhou Z; Sang J; Chen Y; Han Q; Lv Y; Liu Z
    Medicine (Baltimore); 2016 Dec; 95(52):e5749. PubMed ID: 28033288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms of immune checkpoint proteins PD-1 and TIM-3 are associated with survival of patients with hepatitis B virus-related hepatocellular carcinoma.
    Li Z; Li N; Li F; Zhou Z; Sang J; Jin Z; Liu H; Han Q; Lv Y; Liu Z
    Oncotarget; 2016 May; 7(18):26168-80. PubMed ID: 27034168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.